Success Metrics

Clinical Success Rate
50.0%

Based on 2 completed trials

Completion Rate
50%(2/4)
Active Trials
2(22%)
Results Posted
50%(1 trials)
Terminated
2(22%)

Phase Distribution

Ph phase_2
1
11%
Ph not_applicable
3
33%
Ph phase_3
1
11%
Ph phase_1
2
22%

Phase Distribution

2

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
2(28.6%)
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
1(14.3%)
N/ANon-phased studies
3(42.9%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

40.0%

2 of 5 finished

Non-Completion Rate

60.0%

3 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(3)
Completed(2)
Terminated(3)
Other(1)

Detailed Status

Recruiting2
Completed2
Terminated2
Enrolling by invitation1
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (28.6%)
Phase 21 (14.3%)
Phase 31 (14.3%)
N/A3 (42.9%)

Trials by Status

enrolling_by_invitation111%
recruiting222%
completed222%
withdrawn111%
terminated222%
unknown111%

Recent Activity

2 active trials
Showing 5 of 9
recruitingnot_applicable

REMASTer: REcurrent Brain Metastases After SRS Trial

NCT05124912
recruitingphase_1

Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma

NCT07145112
completednot_applicable

Magnetic Resonance-Guided Laser Interstitial Thermal Therapy for Brain Metastases Trial

NCT07132203
enrolling_by_invitationphase_3

Ventral Capsulotomy for Intractable OCD

NCT05659082
unknownphase_1

LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas

NCT05663125
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT05124912Not Applicable

REMASTer: REcurrent Brain Metastases After SRS Trial

Recruiting
NCT07145112Phase 1

Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma

Recruiting
NCT07132203Not Applicable

Magnetic Resonance-Guided Laser Interstitial Thermal Therapy for Brain Metastases Trial

Completed
NCT05659082Phase 3

Ventral Capsulotomy for Intractable OCD

Enrolling By Invitation
NCT05663125Phase 1

LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas

Unknown
NCT03022578Phase 2

Laser Interstitial Thermal Therapy and Lomustine in Treating Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma

Terminated
NCT02224911

Use of Laser Interstitial Thermal Therapy in the Focal Treatment of Localized Prostate Cancer

Completed
NCT01791998Not Applicable

Magnetic Resonance Thermal Image Guided Laser Interstitial Thermal Therapy in Treating Patients With Breast Cancer

Withdrawn
NCT01515085

MRI-Guided Laser Induced Thermal Therapy

Terminated

All 9 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
9